Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
ORYL Photonics logo — Rethinking solubility and aggregation measurement

ORYL Photonics

Rethinking solubility and aggregation measurement

Founded 2020 Switzerland Epalinges, Switzerland 7 employees Series A Total: $3.43M Health Care, Medical Devices

General Information

Company Name ORYL Photonics
Founded Year 2020
Location Switzerland Epalinges, Switzerland +1
Employees 7
Industries Health Care, Medical Devices
Funding Stage Series A
Social

Get notified when ORYL Photonics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ORYL Photonics

ORYL Photonics, founded in 2020 and headquartered in Switzerland, is positioned at the forefront of innovation in the Health Care and Medical Devices sectors. With the compelling slogan, "Rethinking solubility and aggregation measurement," the company addresses a critical bottleneck in drug research and development: the inefficiency of traditional solubility and aggregation tests.

Their flagship product, the ORYL F1, offers a cutting-edge solution by enabling high-throughput, low-compound solubility and aggregation profiling. This innovation empowers pharmaceutical teams by providing decision-ready results in minutes, thereby reducing rework and enhancing the de-risking process of drug discovery.

Recently, ORYL Photonics reached a significant milestone with their Series A investment on 01 September 2025, underscoring investor confidence in their potential to streamline drug development and optimize timelines.

Taxonomy: Solubility Measurement, Aggregation Measurement, High-throughput Screening, Biophysical Triage, Ultrafast Light Scattering, Second Harmonic Scattering, Linear Light Scattering, Formulation Window, Formulation Margin, Excipient Profiling, Surfactant Profiling, Vaccine Formulation, Nanoparticle Characterization, Drug R&D Solutions, Laboratory Instruments

Services & Products

Solubility Measurement Service
Ultrafast and automated profiling platform
High-throughput solubility and aggregation profiling
Non-destructive profiling of biologics
API solubility limit profiling

Target Customers

Pharmaceutical companies Biotech firms R&D laboratories Chemistry researchers Pharmaceutical developers

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• - 01 Sep 2025
Grant •••••• 1
Investor
01 Jul 2024
Seed •••••• 3
Investor Investor Investor
01 Feb 2024
Debt Financing •••••• 1 •••• •••• 01 May 2021
Seed •••••• 1 •••• •••• 01 Feb 2021

View All 6 Funding Rounds

FAQ About ORYL Photonics

Rethinking solubility and aggregation measurement
ORYL Photonics was founded in 2020.
ORYL Photonics is headquartered in Epalinges, Switzerland.
ORYL Photonics operates in the following industries: Health Care, Medical Devices.
ORYL Photonics has approximately 7 employees.
ORYL Photonics has completed 6 funding rounds, raising a total of $3.43M. The latest funding stage is Series A.
ORYL Photonics offers: Solubility Measurement Service, Ultrafast and automated profiling platform, High-throughput solubility and aggregation profiling, Non-destructive profiling of biologics, API solubility limit profiling.

We're actively collecting intelligence on ORYL Photonics.

Track ORYL Photonics to get notified

Don't just browse. Track.

Signal Tracker monitors ORYL Photonics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy